U.S. FDA approves GlaxoSmithKline's blood cancer drug
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.from Top Business News- News18.com https://ift.tt/30BA8kN
For tech Updates :- www.techygears.com
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.
No comments